Chidamide
Tier C — Watch / tradeChidamide
Targets：Ras, C-akt, MAPKs, HDAC3, HDAC2, HDAC10, HDAC1
Brand：Epidaza, Hiyasta
Indications (approved)：Diffuse large B-cell lymphoma, T-cell leukaemia, Breast cancer, Peripheral T-cell lymphoma
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| CHID-001 | 500-22-1 | nicotinaldehyde |
| CHID-002 | 141-82-2Available | malonic acid |
| CHID-003 | 19337-97-4 | (E)-3-(pyridin-3-yl)acrylic acid |
| CHID-004 | 56-91-7 | 4-(aminomethyl)benzoic acid |
| CHID-005 | 219964-34-8 | (E)-4-((3-(pyridin-3-yl)acrylamido)methyl)benzoic acid |
| CHID-006 | 367-31-7 | 4-fluorobenzene-1,2-diamine |
Frequently asked questions
What are the approved indications of Chidamide?
Approved indications include: Diffuse large B-cell lymphoma, T-cell leukaemia, Breast cancer, Peripheral T-cell lymphoma.
When does the Chidamide patent expire?
No public expiry year is available for Chidamide yet; this page updates once verified.
How many synthesis routes are recorded for Chidamide?
1 synthesis routes are recorded; the shortest is 3 steps with 201.2 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Chidamide intermediates?
1 intermediate CAS of Chidamide are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Chidamide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29